Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Turkeli, A. Atici, S. Kayhan (Rize, Samsun, Turkey). Analysis of amylase rich pleural effusions. Eur Respir J 2013; 42: Suppl. 57, 2939

Member's Comments

No comment yet.

Related content which might interest you: Expression of YKL-40 and MIP-1a proteins in exudates and transudates: Biomarkers for differential diagnosis of pleural effusions? Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Association of biochemical determinants and fibrinous formation in malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Pleural complicationsin patients with chronic and end-stage renal disease Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 The role of a pleural service in optimising pleural disease management Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Biological markers of successful pleurodesis for malignant pleural effusion Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside Year: 2016 Screening potential biomarkers for idiopathic pulmonary fibrosis in bronchoalveolar lavage fluid Source: International Congress 2014 – ILDs 1 Year: 2014 High fluorescence cells in pleural fluid. Association with pleural malignancy Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Value of thoracoscopic pleural brush in the diagnosis of exudative pleural effusion Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Pleural disease Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019 Validity of Pleural Fluid Protein in differentiating Tuberculous from Malignant Pleural Effusion Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019 1,25-dihydroxyvitamin D in malignant and non-malignant pleural effusions Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Pleural eicosanoids in patients with lung cancer Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Malignant pleural effusion and incidence of pleural thickening in thorax CT Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Human beta defensin-2 serum levels are lower in complicated infectious pleural effusions Source: Annual Congress 2013 –Interesting research questions Year: 2013 Management of spontaneous pneumothorax in patients with or without Birt-Hogg-Dubé syndrome Source: International Congress 2014 – ILDs 1 Year: 2014 Role of thoracoscopic pleural lavage and brush in undiagnosed exudative pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Yield of pleural cytology and macroscopic pleural invasion in metastatic pleural effusion Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias Source: International Congress 2014 – IPF and surroundings Year: 2014